Shares of PerkinElmer, Inc. (NYSE:PKI – Get Rating) have been given a consensus rating of “Hold” by the twelve research firms that are presently covering the stock, Marketbeat Ratings reports. Six research analysts have rated the stock with a hold rating and five have issued a buy rating on the company. The average twelve-month price objective among brokers that have issued a report on the stock in the last year is $166.30.
A number of analysts recently weighed in on the stock. Robert W. Baird reduced their target price on shares of PerkinElmer from $185.00 to $182.00 and set an “outperform” rating for the company in a report on Wednesday, February 15th. Barclays lowered their price objective on shares of PerkinElmer from $145.00 to $140.00 and set an “equal weight” rating on the stock in a research note on Tuesday, January 24th. TheStreet upgraded PerkinElmer from a “c+” rating to a “b” rating in a research report on Tuesday, February 14th. Credit Suisse Group reiterated a “neutral” rating and set a $160.00 target price on shares of PerkinElmer in a research report on Wednesday, February 15th. Finally, StockNews.com initiated coverage on PerkinElmer in a research note on Thursday, March 16th. They issued a “hold” rating on the stock.
Insider Buying and Selling at PerkinElmer
In other PerkinElmer news, insider Daniel R. Tereau sold 10,741 shares of the firm’s stock in a transaction dated Monday, March 20th. The stock was sold at an average price of $123.72, for a total value of $1,328,876.52. Following the transaction, the insider now directly owns 11,611 shares of the company’s stock, valued at $1,436,512.92. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In other news, insider Daniel R. Tereau sold 10,741 shares of PerkinElmer stock in a transaction that occurred on Monday, March 20th. The shares were sold at an average price of $123.72, for a total value of $1,328,876.52. Following the transaction, the insider now directly owns 11,611 shares of the company’s stock, valued at $1,436,512.92. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Maxwell Krakowiak sold 322 shares of the stock in a transaction that occurred on Wednesday, March 29th. The stock was sold at an average price of $130.00, for a total value of $41,860.00. Following the completion of the transaction, the insider now owns 7,202 shares in the company, valued at approximately $936,260. The disclosure for this sale can be found here. Insiders sold a total of 15,349 shares of company stock valued at $1,953,042 in the last ninety days. Insiders own 0.52% of the company’s stock.
Institutional Trading of PerkinElmer
PerkinElmer Stock Performance
Shares of PerkinElmer stock opened at $131.13 on Friday. The firm’s 50 day moving average is $129.01 and its two-hundred day moving average is $133.85. The firm has a market capitalization of $16.58 billion, a P/E ratio of 28.63, a P/E/G ratio of 0.55 and a beta of 1.10. PerkinElmer has a 52 week low of $113.46 and a 52 week high of $170.00. The company has a quick ratio of 1.87, a current ratio of 2.13 and a debt-to-equity ratio of 0.53.
PerkinElmer (NYSE:PKI – Get Rating) last announced its earnings results on Tuesday, February 14th. The medical research company reported $1.70 earnings per share for the quarter, beating the consensus estimate of $1.66 by $0.04. PerkinElmer had a net margin of 14.69% and a return on equity of 13.94%. The firm had revenue of $741.20 million during the quarter, compared to the consensus estimate of $1.07 billion. During the same quarter in the previous year, the company posted $2.56 EPS. The firm’s revenue for the quarter was down 27.9% on a year-over-year basis. Research analysts forecast that PerkinElmer will post 5.06 EPS for the current fiscal year.
PerkinElmer Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, August 11th. Investors of record on Friday, July 21st will be paid a dividend of $0.07 per share. The ex-dividend date is Thursday, July 20th. This represents a $0.28 annualized dividend and a yield of 0.21%. PerkinElmer’s payout ratio is 6.11%.
PerkinElmer Company Profile
PerkinElmer, Inc engages in the provision of products, services, and solutions for diagnostics, food, environmental, life sciences, and applied markets. It operates through the following segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment consists of technologies that help life sciences researchers better understand diseases and develop treatments.
Featured Stories
- Get a free copy of the StockNews.com research report on PerkinElmer (PKI)
- Investors Are Barking Up The Right Tree With Datadog
- How to Invest in Central Bank Digital Currency
- Kellogg Company Looks GRRR-eat! At These Levels
- PacWest, First Horizon Shares Plummet On Continued Bank Worries
- Yum! Brands Pulls Back To More Appetizing Levels
Receive News & Ratings for PerkinElmer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PerkinElmer and related companies with MarketBeat.com's FREE daily email newsletter.
